Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Interest Income | 100,990 | 97,965 | 97,329 | 101,379 | 102,347 |
| Interest Expense | 22,080 | 23,612 | 25,520 | 26,543 | 27,540 |
| Interest Income (Net of Interest Expense) | 78,910 | 74,353 | 71,809 | 74,836 | 74,807 |
| Non-Interest Income | 44,741 | 31,587 | 32,899 | 29,112 | 34,335 |
| Sales | 123,651 | 105,940 | 104,708 | 103,948 | 109,142 |
| Credit Losses Provision | 4,000 | 4,000 | 4,000 | 6,000 | 10,000 |
| Non Interest Expenses | 87,607 | 88,649 | 85,875 | 86,620 | 91,587 |
| Pre-tax Income | 32,044 | 13,291 | 14,833 | 11,328 | 7,555 |
| Income Tax | -288,842 | 0 | N/A | 0 | N/A |
| Other Income | 54,124 | 36,903 | 40,353 | 37,871 | 35,095 |
| Net Income | $320,886 | $13,291 | $14,833 | $11,328 | $7,555 |
| EPS Basic Continuous Ops | 5.17 | 0.21 | 0.24 | 0.18 | 0.12 |
| EPS Basic Total Ops | 5.17 | 0.21 | 0.24 | 0.18 | 0.12 |
| EPS Diluted Continuous Ops | 5.13 | 0.21 | 0.24 | 0.18 | 0.12 |
| EPS Diluted Total Ops | 5.13 | 0.21 | 0.24 | 0.18 | 0.12 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |